From:  Transcriptional modulation of the PI3K/AKT/mTOR signaling pathway mediated by HPV16 E5, E6, and E7 oncogene expression in breast cancer

 Cliff’s Delta analysis of PI3K/AKT/mTOR pathway regulation in HPV-positive and HPV-negative breast cancer.

GeneMedian HPV+Median HPV–p-valueSignifCliff’s Delta95% CIEffectDirection
EGFR0.066–0.8030.188ns0.268–0.0536 to 0.5389LowHPV+ > HPV–
PI3K–7.488–1.3400.021*0.4600.0014 to 0.7582HighHPV+ >> HPV–
AKT–3.761–2.1680.611ns–0.106–0.4964 to 0.3207IneffectiveHPV+ < HPV–
PTEN–0.3210.7690.157ns–0.288–0.5791 to 0.0694MiddleHPV+ < HPV–
mTOR–10.023–2.394< 0.001***–0.843–0.9713 to –0.3327HighHPV+ << HPV–

ns: not significant; CI: confidence interval. * p-value < 0.05; *** p-value < 0.001.